nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—PGR—polycystic ovary syndrome	0.235	0.302	CbGaD
Spironolactone—SHBG—polycystic ovary syndrome	0.22	0.282	CbGaD
Spironolactone—AR—polycystic ovary syndrome	0.193	0.248	CbGaD
Spironolactone—NR3C1—polycystic ovary syndrome	0.131	0.168	CbGaD
Spironolactone—PGR—corpus luteum—polycystic ovary syndrome	0.0125	0.163	CbGeAlD
Spironolactone—PGR—ovarian follicle—polycystic ovary syndrome	0.00981	0.127	CbGeAlD
Spironolactone—CYP11B2—adrenal cortex—polycystic ovary syndrome	0.00265	0.0343	CbGeAlD
Spironolactone—CYP11B1—adrenal cortex—polycystic ovary syndrome	0.00265	0.0343	CbGeAlD
Spironolactone—NR3C1—urine—polycystic ovary syndrome	0.00237	0.0307	CbGeAlD
Spironolactone—CYP11B1—adrenal gland—polycystic ovary syndrome	0.00191	0.0248	CbGeAlD
Spironolactone—CYP11B2—adrenal gland—polycystic ovary syndrome	0.00191	0.0248	CbGeAlD
Spironolactone—CYP11B1—endocrine gland—polycystic ovary syndrome	0.00166	0.0215	CbGeAlD
Spironolactone—CYP11B2—endocrine gland—polycystic ovary syndrome	0.00166	0.0215	CbGeAlD
Spironolactone—NR3C2—adrenal cortex—polycystic ovary syndrome	0.00117	0.0152	CbGeAlD
Spironolactone—SHBG—endometrium—polycystic ovary syndrome	0.00108	0.014	CbGeAlD
Spironolactone—NR3C2—endometrium—polycystic ovary syndrome	0.00104	0.0135	CbGeAlD
Spironolactone—SHBG—uterus—polycystic ovary syndrome	0.000993	0.0129	CbGeAlD
Spironolactone—SHBG—pituitary gland—polycystic ovary syndrome	0.000976	0.0126	CbGeAlD
Spironolactone—SHBG—adipose tissue—polycystic ovary syndrome	0.000972	0.0126	CbGeAlD
Spironolactone—PGR—endometrium—polycystic ovary syndrome	0.000971	0.0126	CbGeAlD
Spironolactone—NR3C2—uterus—polycystic ovary syndrome	0.000963	0.0125	CbGeAlD
Spironolactone—NR3C2—pituitary gland—polycystic ovary syndrome	0.000945	0.0122	CbGeAlD
Spironolactone—NR3C2—adipose tissue—polycystic ovary syndrome	0.000942	0.0122	CbGeAlD
Spironolactone—PGR—uterus—polycystic ovary syndrome	0.000895	0.0116	CbGeAlD
Spironolactone—PGR—pituitary gland—polycystic ovary syndrome	0.000879	0.0114	CbGeAlD
Spironolactone—PGR—adipose tissue—polycystic ovary syndrome	0.000875	0.0113	CbGeAlD
Spironolactone—SHBG—adrenal gland—polycystic ovary syndrome	0.000872	0.0113	CbGeAlD
Spironolactone—AR—adrenal cortex—polycystic ovary syndrome	0.000866	0.0112	CbGeAlD
Spironolactone—NR3C2—adrenal gland—polycystic ovary syndrome	0.000845	0.0109	CbGeAlD
Spironolactone—SHBG—female gonad—polycystic ovary syndrome	0.000813	0.0105	CbGeAlD
Spironolactone—SHBG—vagina—polycystic ovary syndrome	0.000808	0.0105	CbGeAlD
Spironolactone—NR3C2—female gonad—polycystic ovary syndrome	0.000787	0.0102	CbGeAlD
Spironolactone—PGR—adrenal gland—polycystic ovary syndrome	0.000785	0.0102	CbGeAlD
Spironolactone—NR3C2—vagina—polycystic ovary syndrome	0.000783	0.0101	CbGeAlD
Spironolactone—AR—endometrium—polycystic ovary syndrome	0.000774	0.01	CbGeAlD
Spironolactone—NR3C1—embryo—polycystic ovary syndrome	0.000766	0.00992	CbGeAlD
Spironolactone—SHBG—endocrine gland—polycystic ovary syndrome	0.000756	0.00979	CbGeAlD
Spironolactone—NR3C2—endocrine gland—polycystic ovary syndrome	0.000732	0.00949	CbGeAlD
Spironolactone—PGR—female gonad—polycystic ovary syndrome	0.000732	0.00948	CbGeAlD
Spironolactone—PGR—vagina—polycystic ovary syndrome	0.000728	0.00942	CbGeAlD
Spironolactone—AR—uterus—polycystic ovary syndrome	0.000713	0.00923	CbGeAlD
Spironolactone—AR—pituitary gland—polycystic ovary syndrome	0.0007	0.00907	CbGeAlD
Spironolactone—AR—adipose tissue—polycystic ovary syndrome	0.000697	0.00903	CbGeAlD
Spironolactone—PGR—endocrine gland—polycystic ovary syndrome	0.000681	0.00882	CbGeAlD
Spironolactone—ABCC2—adrenal gland—polycystic ovary syndrome	0.000674	0.00873	CbGeAlD
Spironolactone—Medroxyprogesterone Acetate—HSD3B2—polycystic ovary syndrome	0.000631	0.0838	CrCbGaD
Spironolactone—SLCO1A2—endocrine gland—polycystic ovary syndrome	0.000628	0.00813	CbGeAlD
Spironolactone—NR3C1—adrenal cortex—polycystic ovary syndrome	0.000628	0.00813	CbGeAlD
Spironolactone—CYP2C8—endometrium—polycystic ovary syndrome	0.000626	0.0081	CbGeAlD
Spironolactone—AR—adrenal gland—polycystic ovary syndrome	0.000625	0.0081	CbGeAlD
Spironolactone—ABCC2—endocrine gland—polycystic ovary syndrome	0.000585	0.00757	CbGeAlD
Spironolactone—AR—female gonad—polycystic ovary syndrome	0.000583	0.00755	CbGeAlD
Spironolactone—AR—vagina—polycystic ovary syndrome	0.00058	0.00751	CbGeAlD
Spironolactone—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000566	0.00733	CbGeAlD
Spironolactone—NR3C1—endometrium—polycystic ovary syndrome	0.00056	0.00726	CbGeAlD
Spironolactone—Dydrogesterone—PGR—polycystic ovary syndrome	0.000554	0.0736	CrCbGaD
Spironolactone—AR—endocrine gland—polycystic ovary syndrome	0.000542	0.00702	CbGeAlD
Spironolactone—NR3C1—uterus—polycystic ovary syndrome	0.000516	0.00669	CbGeAlD
Spironolactone—NR3C1—pituitary gland—polycystic ovary syndrome	0.000507	0.00657	CbGeAlD
Spironolactone—NR3C1—adipose tissue—polycystic ovary syndrome	0.000505	0.00654	CbGeAlD
Spironolactone—Oxandrolone—AR—polycystic ovary syndrome	0.000493	0.0656	CrCbGaD
Spironolactone—CYP2C8—vagina—polycystic ovary syndrome	0.000469	0.00607	CbGeAlD
Spironolactone—NR3C1—adrenal gland—polycystic ovary syndrome	0.000453	0.00587	CbGeAlD
Spironolactone—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000439	0.00568	CbGeAlD
Spironolactone—NR3C1—female gonad—polycystic ovary syndrome	0.000422	0.00547	CbGeAlD
Spironolactone—NR3C1—vagina—polycystic ovary syndrome	0.00042	0.00544	CbGeAlD
Spironolactone—ABCB1—embryo—polycystic ovary syndrome	0.00041	0.00531	CbGeAlD
Spironolactone—NR3C1—endocrine gland—polycystic ovary syndrome	0.000393	0.00509	CbGeAlD
Spironolactone—Medroxyprogesterone Acetate—AKR1C3—polycystic ovary syndrome	0.000349	0.0464	CrCbGaD
Spironolactone—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000336	0.00435	CbGeAlD
Spironolactone—Megestrol acetate—PGR—polycystic ovary syndrome	0.000333	0.0443	CrCbGaD
Spironolactone—Testosterone Propionate—CYP17A1—polycystic ovary syndrome	0.000329	0.0438	CrCbGaD
Spironolactone—Testolactone—CYP19A1—polycystic ovary syndrome	0.000308	0.041	CrCbGaD
Spironolactone—ABCB1—endometrium—polycystic ovary syndrome	0.0003	0.00389	CbGeAlD
Spironolactone—Drospirenone—PGR—polycystic ovary syndrome	0.000291	0.0387	CrCbGaD
Spironolactone—ABCB1—uterus—polycystic ovary syndrome	0.000276	0.00358	CbGeAlD
Spironolactone—ABCB1—pituitary gland—polycystic ovary syndrome	0.000271	0.00352	CbGeAlD
Spironolactone—ABCB1—adipose tissue—polycystic ovary syndrome	0.00027	0.0035	CbGeAlD
Spironolactone—ABCB1—adrenal gland—polycystic ovary syndrome	0.000243	0.00314	CbGeAlD
Spironolactone—Drospirenone—AR—polycystic ovary syndrome	0.000239	0.0317	CrCbGaD
Spironolactone—ABCB1—female gonad—polycystic ovary syndrome	0.000226	0.00293	CbGeAlD
Spironolactone—ABCB1—vagina—polycystic ovary syndrome	0.000225	0.00291	CbGeAlD
Spironolactone—Fludrocortisone—AR—polycystic ovary syndrome	0.000225	0.0298	CrCbGaD
Spironolactone—Fluoxymesterone—SHBG—polycystic ovary syndrome	0.000212	0.0281	CrCbGaD
Spironolactone—ABCB1—endocrine gland—polycystic ovary syndrome	0.00021	0.00272	CbGeAlD
Spironolactone—Testosterone Propionate—AR—polycystic ovary syndrome	0.0002	0.0266	CrCbGaD
Spironolactone—Hydrocortamate—NR3C1—polycystic ovary syndrome	0.000195	0.0259	CrCbGaD
Spironolactone—Medroxyprogesterone Acetate—PGR—polycystic ovary syndrome	0.000194	0.0258	CrCbGaD
Spironolactone—Cortisone acetate—NR3C1—polycystic ovary syndrome	0.000192	0.0255	CrCbGaD
Spironolactone—Fluoxymesterone—AR—polycystic ovary syndrome	0.000186	0.0246	CrCbGaD
Spironolactone—Megestrol acetate—NR3C1—polycystic ovary syndrome	0.000185	0.0246	CrCbGaD
Spironolactone—Medroxyprogesterone Acetate—SHBG—polycystic ovary syndrome	0.000182	0.0241	CrCbGaD
Spironolactone—Methyltestosterone—SHBG—polycystic ovary syndrome	0.000171	0.0227	CrCbGaD
Spironolactone—Medroxyprogesterone Acetate—AR—polycystic ovary syndrome	0.000159	0.0211	CrCbGaD
Spironolactone—Fludrocortisone—NR3C1—polycystic ovary syndrome	0.000152	0.0202	CrCbGaD
Spironolactone—Progesterone—CYP17A1—polycystic ovary syndrome	0.000151	0.0201	CrCbGaD
Spironolactone—Methyltestosterone—AR—polycystic ovary syndrome	0.00015	0.0199	CrCbGaD
Spironolactone—Testosterone—CYP11A1—polycystic ovary syndrome	0.000141	0.0187	CrCbGaD
Spironolactone—Hydrocortisone—SHBG—polycystic ovary syndrome	0.000129	0.0171	CrCbGaD
Spironolactone—Fluoxymesterone—NR3C1—polycystic ovary syndrome	0.000126	0.0167	CrCbGaD
Spironolactone—Methyltestosterone—CYP19A1—polycystic ovary syndrome	0.000125	0.0167	CrCbGaD
Spironolactone—Progesterone—PGR—polycystic ovary syndrome	0.000112	0.0149	CrCbGaD
Spironolactone—Medroxyprogesterone Acetate—NR3C1—polycystic ovary syndrome	0.000108	0.0143	CrCbGaD
Spironolactone—Progesterone—SHBG—polycystic ovary syndrome	0.000105	0.0139	CrCbGaD
Spironolactone—Testosterone—SHBG—polycystic ovary syndrome	9.91e-05	0.0132	CrCbGaD
Spironolactone—Progesterone—AR—polycystic ovary syndrome	9.19e-05	0.0122	CrCbGaD
Spironolactone—Testosterone—AR—polycystic ovary syndrome	8.69e-05	0.0115	CrCbGaD
Spironolactone—Hydrocortisone—NR3C1—polycystic ovary syndrome	7.65e-05	0.0102	CrCbGaD
Spironolactone—Testosterone—CYP19A1—polycystic ovary syndrome	7.27e-05	0.00966	CrCbGaD
Spironolactone—Progesterone—NR3C1—polycystic ovary syndrome	6.23e-05	0.00828	CrCbGaD
Spironolactone—Progesterone—CYP1A1—polycystic ovary syndrome	5.66e-05	0.00752	CrCbGaD
Spironolactone—Testosterone—CYP1A1—polycystic ovary syndrome	5.35e-05	0.00711	CrCbGaD
Spironolactone—CYP11B1—Metabolism—AKR1C1—polycystic ovary syndrome	3.47e-05	0.000255	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—YAP1—polycystic ovary syndrome	3.46e-05	0.000254	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	3.43e-05	0.000252	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	3.36e-05	0.000247	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.35e-05	0.000246	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—NAMPT—polycystic ovary syndrome	3.33e-05	0.000244	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—YAP1—polycystic ovary syndrome	3.32e-05	0.000244	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.31e-05	0.000243	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP11A1—polycystic ovary syndrome	3.29e-05	0.000241	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PNPLA2—polycystic ovary syndrome	3.28e-05	0.000241	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	3.28e-05	0.000241	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	3.27e-05	0.000241	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	3.26e-05	0.00024	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.26e-05	0.00024	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.24e-05	0.000238	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—NCOR1—polycystic ovary syndrome	3.23e-05	0.000238	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—SULT2A1—polycystic ovary syndrome	3.2e-05	0.000235	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	3.18e-05	0.000233	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	3.12e-05	0.000229	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SRD5A1—polycystic ovary syndrome	3.11e-05	0.000228	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKR1C3—polycystic ovary syndrome	3.1e-05	0.000228	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—RRM2—polycystic ovary syndrome	3.1e-05	0.000227	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP17A1—polycystic ovary syndrome	3.05e-05	0.000224	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FSHR—polycystic ovary syndrome	3.05e-05	0.000224	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—IL6—polycystic ovary syndrome	3.04e-05	0.000223	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.03e-05	0.000222	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—NR3C1—polycystic ovary syndrome	2.99e-05	0.00022	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—YAP1—polycystic ovary syndrome	2.98e-05	0.000219	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.98e-05	0.000219	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—STAR—polycystic ovary syndrome	2.97e-05	0.000218	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.97e-05	0.000218	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.95e-05	0.000217	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.93e-05	0.000215	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	2.93e-05	0.000215	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—TNRC6B—polycystic ovary syndrome	2.93e-05	0.000215	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	2.92e-05	0.000215	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	2.88e-05	0.000212	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—IL6—polycystic ovary syndrome	2.87e-05	0.000211	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NAMPT—polycystic ovary syndrome	2.87e-05	0.000211	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	2.87e-05	0.000211	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—RPL37A—polycystic ovary syndrome	2.86e-05	0.00021	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.85e-05	0.000209	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP11A1—polycystic ovary syndrome	2.83e-05	0.000208	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.81e-05	0.000207	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.79e-05	0.000205	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.79e-05	0.000205	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	2.78e-05	0.000205	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FST—polycystic ovary syndrome	2.72e-05	0.0002	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—AR—polycystic ovary syndrome	2.7e-05	0.000199	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.7e-05	0.000198	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.68e-05	0.000197	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKR1C3—polycystic ovary syndrome	2.67e-05	0.000196	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NMNAT3—polycystic ovary syndrome	2.66e-05	0.000195	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	2.66e-05	0.000195	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LHB—polycystic ovary syndrome	2.65e-05	0.000195	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—HMMR—polycystic ovary syndrome	2.64e-05	0.000194	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—TH—polycystic ovary syndrome	2.64e-05	0.000194	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	2.64e-05	0.000194	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP17A1—polycystic ovary syndrome	2.63e-05	0.000193	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.59e-05	0.00019	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—SLC2A4—polycystic ovary syndrome	2.57e-05	0.000189	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	2.54e-05	0.000186	CbGpPWpGaD
Spironolactone—AR—Gene Expression—YAP1—polycystic ovary syndrome	2.53e-05	0.000186	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—HSD3B1—polycystic ovary syndrome	2.52e-05	0.000185	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.51e-05	0.000184	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.49e-05	0.000183	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	2.49e-05	0.000183	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.49e-05	0.000183	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SCT—polycystic ovary syndrome	2.49e-05	0.000183	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	2.48e-05	0.000183	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	2.48e-05	0.000182	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SUOX—polycystic ovary syndrome	2.43e-05	0.000179	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LPCAT2—polycystic ovary syndrome	2.43e-05	0.000179	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP19A1—polycystic ovary syndrome	2.42e-05	0.000178	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	2.4e-05	0.000177	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.37e-05	0.000174	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.36e-05	0.000174	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	2.36e-05	0.000174	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGF18—polycystic ovary syndrome	2.33e-05	0.000171	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	2.32e-05	0.00017	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—PPARG—polycystic ovary syndrome	2.32e-05	0.00017	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RBP4—polycystic ovary syndrome	2.31e-05	0.00017	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—LHB—polycystic ovary syndrome	2.3e-05	0.000169	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	2.3e-05	0.000169	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—TH—polycystic ovary syndrome	2.28e-05	0.000167	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.27e-05	0.000167	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	2.27e-05	0.000166	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ISYNA1—polycystic ovary syndrome	2.26e-05	0.000166	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—POMC—polycystic ovary syndrome	2.26e-05	0.000166	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AR—polycystic ovary syndrome	2.25e-05	0.000165	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—HSD3B2—polycystic ovary syndrome	2.25e-05	0.000165	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	2.23e-05	0.000164	CbGpPWpGaD
Spironolactone—AR—Gene Expression—TNRC6B—polycystic ovary syndrome	2.23e-05	0.000164	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—SLC2A4—polycystic ovary syndrome	2.22e-05	0.000163	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	2.21e-05	0.000162	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PGR—polycystic ovary syndrome	2.21e-05	0.000162	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKR1C1—polycystic ovary syndrome	2.18e-05	0.00016	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GNAS—polycystic ovary syndrome	2.16e-05	0.000159	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—YAP1—polycystic ovary syndrome	2.16e-05	0.000158	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GAB1—polycystic ovary syndrome	2.13e-05	0.000156	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	2.12e-05	0.000156	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	2.12e-05	0.000156	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—SERPINE1—polycystic ovary syndrome	2.09e-05	0.000153	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP19A1—polycystic ovary syndrome	2.08e-05	0.000153	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	2.06e-05	0.000152	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—NCOR1—polycystic ovary syndrome	2.06e-05	0.000151	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—INSR—polycystic ovary syndrome	2.03e-05	0.000149	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	2.01e-05	0.000148	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SULT2A1—polycystic ovary syndrome	2e-05	0.000147	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—IL6—polycystic ovary syndrome	1.99e-05	0.000146	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	1.97e-05	0.000145	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NCOR1—polycystic ovary syndrome	1.97e-05	0.000145	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.96e-05	0.000144	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP1A1—polycystic ovary syndrome	1.95e-05	0.000143	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—RRM2—polycystic ovary syndrome	1.94e-05	0.000143	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	1.93e-05	0.000142	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TEAD2—polycystic ovary syndrome	1.92e-05	0.000141	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKR1C2—polycystic ovary syndrome	1.92e-05	0.000141	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—YAP1—polycystic ovary syndrome	1.92e-05	0.000141	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.9e-05	0.00014	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—YAP1—polycystic ovary syndrome	1.87e-05	0.000137	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GNAS—polycystic ovary syndrome	1.86e-05	0.000137	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.85e-05	0.000136	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NR3C1—polycystic ovary syndrome	1.82e-05	0.000134	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.82e-05	0.000134	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—MTHFR—polycystic ovary syndrome	1.82e-05	0.000133	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NAMPT—polycystic ovary syndrome	1.8e-05	0.000132	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.79e-05	0.000131	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP11A1—polycystic ovary syndrome	1.78e-05	0.00013	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NCOR1—polycystic ovary syndrome	1.77e-05	0.00013	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.76e-05	0.000129	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GHRL—polycystic ovary syndrome	1.75e-05	0.000129	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PLAT—polycystic ovary syndrome	1.75e-05	0.000129	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	1.74e-05	0.000128	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	1.72e-05	0.000126	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	1.69e-05	0.000124	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—TNRC6B—polycystic ovary syndrome	1.69e-05	0.000124	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP1A1—polycystic ovary syndrome	1.68e-05	0.000123	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKR1C3—polycystic ovary syndrome	1.68e-05	0.000123	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	1.68e-05	0.000123	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	1.68e-05	0.000123	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PGR—polycystic ovary syndrome	1.67e-05	0.000123	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ATF1—polycystic ovary syndrome	1.67e-05	0.000123	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP17A1—polycystic ovary syndrome	1.65e-05	0.000121	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.63e-05	0.00012	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PNPLA2—polycystic ovary syndrome	1.61e-05	0.000118	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—MTHFR—polycystic ovary syndrome	1.57e-05	0.000115	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NGFR—polycystic ovary syndrome	1.54e-05	0.000113	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	1.53e-05	0.000112	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PRL—polycystic ovary syndrome	1.53e-05	0.000112	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	1.53e-05	0.000112	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	1.52e-05	0.000111	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NCOR1—polycystic ovary syndrome	1.5e-05	0.00011	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	1.49e-05	0.00011	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PPARG—polycystic ovary syndrome	1.47e-05	0.000108	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	1.46e-05	0.000107	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—POMC—polycystic ovary syndrome	1.45e-05	0.000107	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.45e-05	0.000106	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—INS—polycystic ovary syndrome	1.44e-05	0.000106	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.44e-05	0.000106	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TH—polycystic ovary syndrome	1.43e-05	0.000105	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PPARG—polycystic ovary syndrome	1.41e-05	0.000104	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	1.4e-05	0.000103	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SLC2A4—polycystic ovary syndrome	1.39e-05	0.000102	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.39e-05	0.000102	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NR3C1—polycystic ovary syndrome	1.39e-05	0.000102	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GNAS—polycystic ovary syndrome	1.34e-05	9.87e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	1.33e-05	9.78e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP19A1—polycystic ovary syndrome	1.31e-05	9.6e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AR—polycystic ovary syndrome	1.3e-05	9.57e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	1.3e-05	9.55e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.28e-05	9.41e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—SERPINE1—polycystic ovary syndrome	1.27e-05	9.34e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—STAR—polycystic ovary syndrome	1.27e-05	9.33e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.27e-05	9.33e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PPARG—polycystic ovary syndrome	1.27e-05	9.33e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NRG1—polycystic ovary syndrome	1.26e-05	9.23e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—POMC—polycystic ovary syndrome	1.25e-05	9.2e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—INS—polycystic ovary syndrome	1.24e-05	9.15e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	1.24e-05	9.11e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.23e-05	9e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GNAS—polycystic ovary syndrome	1.17e-05	8.56e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.16e-05	8.53e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NCOR1—polycystic ovary syndrome	1.14e-05	8.36e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.14e-05	8.34e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	1.13e-05	8.32e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	1.13e-05	8.31e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NCOR1—polycystic ovary syndrome	1.11e-05	8.16e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	1.1e-05	8.12e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	1.08e-05	7.93e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IRS2—polycystic ovary syndrome	1.08e-05	7.91e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PPARG—polycystic ovary syndrome	1.08e-05	7.9e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	1.07e-05	7.86e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.07e-05	7.83e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LEP—polycystic ovary syndrome	1.05e-05	7.74e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.05e-05	7.73e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LHB—polycystic ovary syndrome	9.85e-06	7.24e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	9.85e-06	7.24e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MTHFR—polycystic ovary syndrome	9.81e-06	7.21e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SERPINE1—polycystic ovary syndrome	9.69e-06	7.12e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	9.63e-06	7.07e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	9.54e-06	7.01e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IRS1—polycystic ovary syndrome	9.4e-06	6.9e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	9.32e-06	6.85e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	9.19e-06	6.75e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—POMC—polycystic ovary syndrome	9.05e-06	6.65e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—INS—polycystic ovary syndrome	9e-06	6.61e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	8.83e-06	6.49e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.78e-06	6.45e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	8.72e-06	6.41e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1—polycystic ovary syndrome	8.7e-06	6.39e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT2—polycystic ovary syndrome	8.7e-06	6.39e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.66e-06	6.36e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	8.58e-06	6.3e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	8.31e-06	6.1e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.27e-06	6.07e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	8.24e-06	6.05e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARG—polycystic ovary syndrome	8.16e-06	5.99e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	8.11e-06	5.96e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	8.01e-06	5.88e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARG—polycystic ovary syndrome	7.96e-06	5.85e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—POMC—polycystic ovary syndrome	7.85e-06	5.77e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—INS—polycystic ovary syndrome	7.81e-06	5.73e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	7.7e-06	5.65e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	7.6e-06	5.58e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SERPINE1—polycystic ovary syndrome	7.35e-06	5.4e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	7.18e-06	5.27e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	7.07e-06	5.19e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TH—polycystic ovary syndrome	7.02e-06	5.16e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	6.83e-06	5.02e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	6.42e-06	4.72e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TH—polycystic ovary syndrome	6.11e-06	4.49e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	5.95e-06	4.37e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	5.73e-06	4.21e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.69e-06	4.18e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	5.59e-06	4.11e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	5.46e-06	4.01e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	5.17e-06	3.8e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	4.99e-06	3.67e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	4.82e-06	3.54e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	4.75e-06	3.49e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	4.51e-06	3.31e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	4.2e-06	3.09e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—polycystic ovary syndrome	3.93e-06	2.89e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	3.91e-06	2.87e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	3.86e-06	2.83e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—INS—polycystic ovary syndrome	3.84e-06	2.82e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	3.41e-06	2.5e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—POMC—polycystic ovary syndrome	3.36e-06	2.47e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—INS—polycystic ovary syndrome	3.34e-06	2.46e-05	CbGpPWpGaD
